Analysts Anticipate Senseonics Holdings Inc (SENS) to Post -$0.13 EPS

Brokerages forecast that Senseonics Holdings Inc (NASDAQ:SENS) will report earnings of ($0.13) per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Senseonics Holdings’ earnings. The lowest EPS estimate is ($0.15) and the highest is ($0.10). Senseonics Holdings also reported earnings of ($0.13) per share in the same quarter last year. The firm is scheduled to announce its next quarterly earnings results after the market closes on Wednesday, August 9th.

On average, analysts expect that Senseonics Holdings will report full-year earnings of ($0.55) per share for the current fiscal year, with EPS estimates ranging from ($0.56) to ($0.54). For the next year, analysts forecast that the business will report earnings of ($0.61) per share, with EPS estimates ranging from ($0.81) to ($0.45). Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that cover Senseonics Holdings.

Several brokerages recently weighed in on SENS. Zacks Investment Research downgraded shares of Senseonics Holdings from a “hold” rating to a “sell” rating in a report on Wednesday. BTIG Research reaffirmed a “buy” rating and issued a $4.50 target price on shares of Senseonics Holdings in a report on Sunday, May 28th. Finally, B. Riley reaffirmed a “buy” rating and issued a $4.00 target price on shares of Senseonics Holdings in a report on Friday, May 5th.

In related news, major shareholder Enterprise Associates 10 L. New purchased 7,092,198 shares of the firm’s stock in a transaction on Thursday, June 1st. The shares were acquired at an average price of $1.41 per share, for a total transaction of $9,999,999.18. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.

Several hedge funds have recently made changes to their positions in SENS. LMR Partners LLP acquired a new stake in shares of Senseonics Holdings during the second quarter valued at about $177,000. NEA Management Company LLC boosted its stake in shares of Senseonics Holdings by 27.1% in the second quarter. NEA Management Company LLC now owns 33,425,275 shares of the company’s stock valued at $60,165,000 after buying an additional 7,119,989 shares in the last quarter. ING Groep NV boosted its stake in shares of Senseonics Holdings by 87.7% in the second quarter. ING Groep NV now owns 225,833 shares of the company’s stock valued at $406,000 after buying an additional 105,494 shares in the last quarter. Blackstone Group L.P. acquired a new stake in shares of Senseonics Holdings during the first quarter valued at about $614,000. Finally, HarbourVest Partners LLC acquired a new stake in shares of Senseonics Holdings during the first quarter valued at about $470,000.

COPYRIGHT VIOLATION WARNING: “Analysts Anticipate Senseonics Holdings Inc (SENS) to Post -$0.13 EPS” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.com-unik.info/2017/08/19/analysts-anticipate-senseonics-holdings-inc-sens-to-post-0-13-eps-updated.html.

Shares of Senseonics Holdings (NASDAQ:SENS) traded up 0.90% during trading on Wednesday, reaching $2.24. The company’s stock had a trading volume of 245,777 shares. Senseonics Holdings has a one year low of $1.26 and a one year high of $4.24. The company’s market capitalization is $210.79 million. The firm’s 50-day moving average price is $2.08 and its 200-day moving average price is $1.99.

Senseonics Holdings Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Get a free copy of the Zacks research report on Senseonics Holdings (SENS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

What are top analysts saying about Senseonics Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Senseonics Holdings Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit